LivaNova PLC (LIVN)

LivaNova Revenue

LivaNova had revenue of $390.59M in the quarter ending June 30, 2026, with 10.80% growth. This brings the company's total for the last twelve months to $1.47B, up 12.39% year-over-year. In the year 2025, LivaNova had annual revenue of $1.39B with 10.74% growth. That makes LivaNova the 6,056th largest company in the world by revenue and 1,517th in the United States.

• Revenue (ttm): $1.47B
• Revenue Growth: +12.39%
• P/S Ratio: 2.96
• Revenue / Employee: $445,915
• Employees: 3,300
• Market Cap: 4.35B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Cardiopulmonary 785.39M 56.6%
• Neuromodulation 592.81M 42.7%
• Other 9.86M 0.7%

By Geography

Chart

• United States 739.57M 53.3%
• Rest of World 379.30M 27.3%
• Europe (Excluding United Kingdom) 213.28M 15.4%
• United Kingdom 55.90M 4.0%

Fiscal year ended Dec 31, 2025 See the full LivaNova breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.39B	134.62M	10.74%
Dec 31, 2024	1.25B	99.89M	8.66%
Dec 31, 2023	1.15B	131.74M	12.89%
Dec 31, 2022	1.02B	-13.56M	-1.31%
Dec 31, 2021	1.04B	101.12M	10.82%
Dec 31, 2020	934.24M	-149.93M	-13.83%
Dec 31, 2019	1.08B	-22.79M	-2.06%
Dec 31, 2018	1.11B	94.68M	9.35%
Dec 31, 2017	1.01B	47.42M	4.91%
Dec 31, 2016	964.86M	673.30M	230.93%
Apr 24, 2015	291.56M	9.54M	3.38%
Apr 25, 2014	282.01M	27.69M	10.89%
Apr 26, 2013	254.32M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error